News

According to hematopoietic stem cells (HSC) model, the two progenitor cell types, T and B cells, lose the potential to develop into non-lymphocytes (myeloid cells) once they pass

Invitrogen, the parent of CellzDirect, is a wholly-owned subsidiary of Life Technologies of Carlsbad, California. The complaint alleges that certain processes and methods performed by CellzDirect associated with

Watson Pharmaceuticals said that the launch was a part of a settlement agreement with Novartis Pharmaceuticals, Novartis Pharma, Novartis AG, Novartis International, and Proterra (collectively Novartis). Exelon is

As per the terms of the agreement, Nuokang is expected to get license to register, market and distribute Dianatal Obstetric Gel in Mainland China, Hong Kong, Macao and

As per the terms of the agreement, JHP is expected to take up the responsibility for manufacturing and supply of a proprietary ophthalmic product, which is targeted for

Under the terms of the agreement, X-Chem is expected to get an upfront and research payments, success-based discovery milestones, and technology access fees from Roche. Roche is expected

The alliance between Servier and Galapagos builds on novel OA drug targets discovered by Galapagos through its proprietary platform. Galapagos is expected to take up the responsibility of

Afinitor is approved for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted

The arrangement, which is effective as of the July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with